Cell and Gene Therapy CDMO Market Overview: The global Cell and Gene Therapy CDMO Market is anticipated to witness a CAGR of 27% during the forecast period, driven by the growing burden of cancer and ...

OmniaBio, a CDMO focused on cell and gene therapies, debuted a new manufacturing facility it claims to be the largest of its kind in Canada. The 120,000-square-foot site, which is located just outside ...

The MarketWatch News Department was not involved in the creation of this content. PHILADELPHIA and LONDON, Dec. 18, 2025 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract ...

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology (Matica Bio) announced today that it will participate in the world’s largest biotech exhibition, the BIO International Convention (BIO USA ...

- Inks a Memorandum of Understanding (MOU) with CRC, a member of Alfresa Group, a leading Japanese pharmaceutical distributor, to collaborate on cell and gene therapy (CGT). SEOUL, South ...

SINGAPORE, March 11, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River ...

According to the latest study from BCC Research, the demand for “Global Market Opportunities and Competitive Landscape for CDMOs” was valued at $128.0 billion in 2023 and is expected to grow from $136 ...

Andelyn Biosciences, (Andelyn), a leading and patient-focused cell and gene therapy contract development and manufacturing organization (CDMO), and ENCell Co., Ltd. (ENCell), a Korea-based advanced ...

Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded its ...

Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing ...